About Us
Company
Journey So Far
Board of Directors
Our Expertise
Manufacturing
Research & Development
Quality Assurance & Regulatory Affairs
Products
Business
CDMO Services and Products
Domestic Branded Generics
International Branded Generics
Investor Relations
Financial Information
Draft Red Herring Prospectus(DRHP)
Red Herring Prospectus(RHP)
Prospectus
Corporate Governance
Disclosure under regulation 46 of SEBI
Industry Report
Earning Call
Latest Circular
Investor Contact
CSR
Corporate Social Responsibilities
Health, Safety & Environment
Environmental, Social & Governance
Careers
Contact Us
Investor Relations
Home
Investor Relations
Financial Information
Innova Captab Ltd.
Financial Results 2018-19
[Download]
Financial Results 2019-20
[Download]
Financial Results 2020-21
[Download]
Financial Results 2021-22
[Download]
Financial Results 2022-23
[Download]
Financial Results 2023-24 Q2
[Download]
Financial Results 2023-24 Q3
[Download]
Financial Results 2023-24 Q4
[Download]
Consolidated Financial Statements:-
Financial Statement 2021-22
[Download]
Financial Statement 2022-23
[Download]
Financial Statement 2023-24 Q2
[Download]
Financial Statement 2023-24- Q3
[Download]
Financial Statement 2023-24 Q4
[Download]
Univentis Medicare Ltd.
Financial Results 2018-19
[Download]
Financial Results 2019-20
[Download]
Financial Results 2020-21
[Download]
Financial Results 2021-22
[Download]
Financial Results 2022-23
[Download]
Financial Results 2023-24
[Download]
Sharon Bio Medicine Limited
Financials 2023
[Download]
SBML- Financial Results 2023-24
[Download]
Univentis Foundation
Financials Results 2022-23
[Download]
Financial Results 2023-24
[Download]
Draft Red Herring Prospectus (DRHP)
Draft Red Herring Prospectus
[Download]
Addendum to the DRHP
[Download]
Red Herring Prospectus (RHP)
Red Herring Prospectus
[Download]
Prospectus
Prospectus
[Download]
Corporate Governance
Company Policies
MATERIALITY POLICY
[Download]
CONTACT DETAILS OF KEY MANAGERIAL PERSONNEL (KMP) FOR THE PURPOSE OF DETERMINING MATERIALITY OF EVENT
[Download]
CREDIT RATING
[Download]
TERMS & CONDITIONS_APPOINTMENT OF INDEPENDENT DIRECTORS
[Download]
ARCHIVAL POLICY
[Download]
CODE OF CONDUCT FOR BOARD OF DIRECTORS AND SENIOR MANAGEMENT PERSONNEL
[Download]
CODE OF INTERNAL PROCEDURES AND CONDUCT FOR REGULATING, MONITORING AND REPORTING OF TRADING BY INSIDERS
[Download]
POLICY FOR CORPORATE SOCIAL RESPONSIBILITY
[Download]
POLICY FOR DETERMINATION OF MATERIALITY
[Download]
POLICY FOR DETERMINING MATERIAL SUBSIDIARIES
[Download]
POLICY FOR FAMILIARIZATION PROGRAMMES FOR INDEPENDENT DIRECTORS
[Download]
POLICY FOR NOMINATION & REMUNERATION
[Download]
POLICY FOR RISK MANAGEMENT
[Download]
POLICY FOR VIGIL MECHANISM AND WHISTLE BLOWER
[Download]
POLICY ON MATERIALITY OF RELATED PARTY TRANSACTIONS AND ON DEALING WITH RELATED PARTY TRANSACTIONS
[Download]
POLICY ON PRESERVATION OF DOCUMENTS
[Download]
POLICY ON PREVENTION OF SEXUAL HARASSMENT AT THE WORKPLACE
[Download]
POLICY ON SUCCESSION PLANNING FOR THE BOARD AND SENIOR MANAGEMENT
[Download]
POLICY TO PROMOTE DIVERSITY
[Download]
LABOUR & HUMAN RIGHTS POLICY
[Download]
PERFORMANCE EVALUATION POLICY
[Download]
INVESTORS GRIEVANCE POLICY
[Download]
ESG POLICY
[Download]
CYBER SECURITY POLICY
[Download]
FAMILIARIZATION PROGRAM
[Download]
CODE OF PRACTICES AND PROCEDURES FOR FAIR DISCLOSURE OF UPSI
[Download]
DIVIDEND DISTRIBUTION POLICY
[Download]
Committee Constitution
Committee Constitution
[Download]
Material Creditors
Material Creditors 31 December 2021
[Download]
Material Creditors 30 June 2023
[Download]
Material Contracts for the Offer
1.
(a) Offer Agreement dated June 28,2022 .
[Download]
(b) The amendment agreement to the Offer Agreement dated September 12, 2023,
[Download]
(c) The amendment agreement to the Offer Agreement dated December 13, 2023.
[Download]
2.
(a) Registrar Agreement dated June 20, 2022.
[Download]
(b) The amendment agreement dated December 8, 2023.
[Download]
3.
Cash Escrow and Sponsor Bank Agreement dated December 12, 2023.
[Download]
4.
Share Escrow Agreement dated December 7, 2023 and the amendment agreement dated December 13, 2023.
[Download]
5.
Syndicate Agreement dated December 13, 2023.
[Download]
6.
Monitoring Agency Agreement dated December 6, 2023
[Download]
Material documents
1.
Certified copies of the Memorandum of Association and Articles of Association
[Download]
2.
Certificate of incorporation dated January 3, 2005.
[Download]
3.
Fresh certificate of incorporation consequent to change of our name to ‘Innova Captab Private Limited’ dated February 2, 2010.
[Download]
4.
Fresh certificate of incorporation consequent upon conversion to public limited company dated July 26,2018.
[Download]
5.
Resolution of the Board of Directors and the Shareholders of our Company dated June 19, 2022, and June 24, 2022, respectively in relation to the Offer and other related matters.
[Download]
6.
Resolution of the Board of Directors of our Company dated June 27, 2022, approving the Draft Red Herring Prospectus.
[Download]
7.
Resolution of the Board of Directors of our Company dated December 14, 2023, approving this Red Herring Prospectus.
[Download]
8.
Consent letters from the Selling Shareholders in relation to the Offer for Sale.
[Download]
9.
Consent dated December 1, 2023 from CRISIL
[Download]
10.
Industry report titled ‘Assessment of Indian pharmaceutical and CDMO market’, dated October 2023, prepared by CRISIL MI&A.
[Download]
11.
Consent from the Statutory Auditors namely, B S R & Co. LLP,
[Download]
12.
Consent letter dated December 14, 2023 from Parashar & Co., Chartered Engineer,
[Download]
13.
Consent letter dated December 14, 2023, from N B T and Co, Chartered Accountants,
[Download]
14.
Consent letter dated December 14, 2023, from N. Bhasin & Associates,
[Download]
15.
Report issued by the Statutory Auditors dated December 14, 2023, on the statement of possible special tax benefits available to our Company, our Shareholders and our Material Subsidiaries.
[Download]
16.
Agreement to sell business dated March 31, 2021, entered into between our Company and Innova Partnership.
[Download]
17.
Share purchase agreement dated December 31, 2021, entered into between our Company, previous shareholders of Univentis Medicare Limited and Univentis Medicare Limited.
[Download]
18.
Share subscription agreement dated July 13, 2022, entered into by our Company with UTI Multi Opportunities Fund I,along with the agreement dated December 1, 2023.
[Download]
19.
Share subscription agreement dated December 1, 2023, entered into by our Company with 360 One Special Opportunities Fund – Series 9, 360 One Special Opportunities Fund – Series 10.
[Download]
20.
Deeds of guarantees in connection with the guarantees as set out under “History and Certain Corporate Matters – Guarantees given by our Promoter Selling Shareholders.
[Download]
21.
Copies of annual reports of our Company for the preceding three Fiscals.
[Download]
22.
Consent letter.
[Download]
23.
Tripartite agreement dated April 6, 2022, amongst our Company, NSDL and the Registrar to the Offer.
[Download]
24.
Tripartite agreement dated March 28, 2022, amongst our Company, CDSL and the Registrar to the Offer.
[Download]
25
Due diligence certificate dated June 28, 2022, addressed to SEBI from the BRLMs.
[Download]
26.
In-principle listing approvals dated September 16, 2022, and September 15, 2022, issued by BSE and NSE,respectively.
[Download]
27.
SEBI observation letter dated January 11, 2023, and the in-seriatim reply of the BRLMs dated December 5,2023.
[Download]
Disclosure under regulation 46 of SEBI
Disclosure under regulation 46 of SEBI
Details of Business
Terms and conditions of appointment of independent directors
Composition of various committees of board of directors
Code of conduct for BOD & SMP
Whistle Blower Policy
Policy on dealing with related party transactions
Policy for determining ‘material’ subsidiaries
Policy for familarisation programme for IDs
Contact information for grievance redressal
Contact information of the designated officials of the listed entity who are responsible for assisting and handling investor grievances
Notice of meeting of the board of directors
Financial results, on conclusion of the meeting of the board of directors where the financial results were approved
Annual Report
Shareholding Pattern
Schedule of analysts or institutional investors meet & Presentation
Audio or video recordings and transcripts of post earnings/quarterly calls
Financial results published in newspaper
Credit Ratings
Financial statement of subsidiary companies
Secretarial compliance report
Policy for determination of materiality of events or information
Contact details of KMP for the purpose of determining materiality of event
Dividend distribution policy
Annual return
Statement of deviation-Q3
Criteria of making payments to Non-Executive Directors
NOTICE OF GENERAL MEETING
AGM Notice_FY 2021-22
AGM Notice_FY 2022-23
Annual Return
Annual Return_FY 2021-22
Annual Return_FY 2022-23
Shareholding Pattern
Shareholding Pattern-December 2023
Shareholding Pattern-March 2024
Shareholding Pattern-June 2024
CORPORATE GOVERNANCE REPORT
Corporate Governance Report- December 2023
Corporate Governance Report-March 2024
Financial Information of Group Companies
Azine Healthcare Pvt. Ltd.
Financial Results 2018-19
Financial Results 2019-20
Financial Results 2020-21
Financial Results 2021-22
Financial Results 2022-23
Nugenic Pharma Pvt. Ltd.
Financial Results 2018-19
Financial Results 2019-20
Financial Results 2020-21
Financial Results 2021-22
Financial Results 2022-23
DMS Electronics Pvt. Ltd.
Financial Results 2018-19
Financial Results 2019-20
Financial Results 2020-21
Financial Results 2021-22
Financial Results 2022-23
Directors' Report
Director Report-FY 2020-21
Director Report-FY 2021-22
Director Report-FY 2022-23
Intimation Stock Exchange
Intimation for Board Meeting - Jan 18, 2024
Quarterly Intimation for Board Meeting - Jan 18, 2024
Related Party Transaction Report - Jan 18, 2024
Intimation for Board Meeting - Feb 13, 2024
Intimation for Earnings call 14 Feb 2024
Intimation of Newspaper advertisement
Board meeting outcome - Feb 13, 2024
Investor Deck Feb 13, 2024
Intimation for Earning Call Recording
Newspaper Advertisement - Feb 14, 2024
Intimation of Delisting- Feb 14, 2024
Conference Call Q3-Feb 14, 2024
Intimation Transcript of Earning Call- Feb 14, 2024
Intimation of CFO Resignation- March 14, 2024
Intimation- Regulation 30- March 21, 2024
Board Meeting Outcome- March 29, 2024
Trading Window Closure Intimation- March 28, 2024
Appointment of CFO-March 29, 2024
Intimation- Regulation 30- April 10, 2024
Compliance Certificate-Regulation 7- April 15, 2024
Compliance Certificate- Regulation 40- April 18th, 2024
Monitoring Agency Report - March 31th, 2024 signed
Board meeting outcome - May 29th, 2024
Press Release- May 29th, 2024
Statement of deviation - March 31st 2024
Related Party Transaction Report-31st March 2024
Investor Deck 30th May 2024
Transcript 30th May 2024
MA Report 30th June 2024
Industry Report
CRISIL Research
CRISIL Indian Pharmaceutical and CDMO Market
[Download]
Earning Call
Con Call 14th Feb 2024
Con Call 30th May 2024
Latest Circular
Latest Circulars
SEBI Circular 27th December 2023
[Download]
SEBI Circular 10th June 2024
[Download]